Veterinary Product Information
Vet > Recombitek Equine West Nile Virus (Canada)
The information provided typically includes the following:
20000 CLARK GRAHAM, BAIE D'URFÉ, QC, H9X 4B6
Recombitek Equine West Nile Virus (Canada)
This page contains information on Recombitek Equine West Nile Virus for veterinary use.The information provided typically includes the following:
- Recombitek Equine West Nile Virus Indications
- Warnings and cautions for Recombitek Equine West Nile Virus
- Direction and dosage information for Recombitek Equine West Nile Virus
Recombitek Equine West Nile Virus
This treatment applies to the following species:Manufacturer: Merial
MERIAL CANADA INC.West Nile Virus Vaccine, Live Canarypox Vector
Description
Contents
RECOMBITEK® Equine West Nile Virus contains a lyophilized recombinant canarypox vectored West Nile Virus vaccine plus a sterile liquid diluent. A canarypox vector has been modified using recombinant technology to express the desired antigens capable of stimulating a protective immune response to West Nile Virus. After inoculation, the vector does not multiply in the horse, but does express the protective proteins. As a consequence, these components induce an immune status against West Nile Virus. Safety and immunogenicity of this vaccine have been demonstrated by vaccination and challenge tests in susceptible horses.Recombitek Equine West Nile Virus Indications
Recombitek® WNV is recommended for the vaccination of healthy horses as an aid in the prevention of viremia due to West Nile Virus infection.Dosage
Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject a 1 ml dose by intramuscular route. For primary vaccination, revaccinate with a second 1 ml dose of this product 4 to 6 weeks later. Annual revaccination with a single dose is recommended.Precautions
Store at 2-7C (35-45F). For the preparation and administration of the vaccine, use sterile and antiseptic-free and/or disinfectant-free material. Burn container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate within 21 days prior to slaughter. As with any vaccine, a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment.SOLD TO VETERNARIANS ONLY.
For Veterinary Use Only.
Manufactured By: MERIAL, INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
1-888-Merial-1 (1-888-637-4251)
Distributed In Canada By: MERIAL CANADA, INC., Baie d'Urfé, Qc H9X 4B6
RECOMBITEK is a registered trademark of MERIAL.
|
Contains |
|
Prod. No. |
|
|
10 Doses |
10 x 1 dose (1 mL) 10 x 1 Dose, Lyophilized 10 x 1 mL, Sterile Diluent |
2418-10 |
RM410R3 |
|
25 Doses |
5 x 5 dose (5 mL) 5 x 5 Dose, Lyophilized 5 x 5 mL, Sterile Diluent |
2418-05 |
RM1011R2 |
Nac No.
1182112120000 CLARK GRAHAM, BAIE D'URFÉ, QC, H9X 4B6
| Telephone: | 514-457-1555 | |
| Order Desk: | 888-637-4251 (888-MERIAL1) | |
| Fax: | 514-457-1175 | |
| Website: | www.merial.com | |
| Email: | service.canada@merial.com |
![]() |
Every effort has been made to ensure the accuracy of the Recombitek Equine West Nile Virus information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Recombitek Equine West Nile Virus product label or package insert. |
![]() |
Printable Version | ![]() |
Email Page |








